- Exchange: Stockholm
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Oasmia Pharmaceutical AB+ Add to Watchlist
OASM:SS20.2000 SEK 0.5000 2.42%
As of 12:00:01 ET on 12/09/2013.
Company Profile for Oasmia Pharmaceutical AB (OASM)
Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.
Oasmia Pharmaceutical AB
Key Executives for Oasmia Pharmaceutical AB (OASM)
|Joel Tomas CitronChairman||Julian AleksovCEO/Co-Founder|
|Weine NejdemoChief Financial Officer||Hans SundinExecutive Vice President|
|Margareta ErikssonVP:Clinical Development||Ingela HagglundVP:Operations|
|Annette LjungmarkHead:Accounting & Human Resources||Mikael AspHead:Quality Assurance|